Which hedge funds own DMRA? DAMORA THERAPEUTICS INC, Q2 2026 13F holders
24 tracked hedge funds disclosed a position in DMRA (DAMORA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $793.8m in total. The largest holder by portfolio weight is Fairmount Funds Management LLC at 15.0% of its book. 5 opened a new position this quarter: Stempoint Capital LP, Citadel Advisors LLC, Verition Fund Management LLC, Adage Capital Partners GP, L.L.C.. 11 exited: Cannon Global Investment Management, LLC, Catalyst Funds Management Pty Ltd, Boothbay Fund Management, LLC.
- 24
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 5
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 11
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $11.8m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $32.0m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $794m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Cannon Global Investment Management, LLC | 0.6% | $241k |
| Catalyst Funds Management Pty Ltd | 0.08% | $448k |
| Boothbay Fund Management, LLC | 0.07% | $2.9m |
| Landscape Capital Management, L.L.C. | 0.04% | $633k |
| Brevan Howard Capital Management LP | 0.01% | $1.4m |
| Hudson Bay Capital Management LP | 0.01% | $2.0m |
| Qube Research & Technologies Ltd | 0.01% | $7.3m |
| Millennium Management LLC | 0.01% | $12.2m |
| Marshall Wace, LLP | 0.0% | $4.4m |
| Y-Intercept (Hong Kong) Ltd | 0.0% | $205k |
| Schonfeld Strategic Advisors LLC | 0.0% | $280k |
Ownership over time
Who discovered DMRA first? Beta
| Ikarian Capital, LLC | Q4 2025 | +0.1 pts |
| Fairmount Funds Management LLC high conviction | Q1 2026 | +0.1 pts |
| Venrock Adviser, LLC | Q1 2026 | 0.0 pts |
| Commodore Capital LP | Q1 2026 | 0.0 pts |
| Cormorant Asset Management, LP | Q1 2026 | 0.0 pts |
| Seven Fleet Capital Management LP | Q1 2026 | 0.0 pts |
| Braidwell LP | Q2 2026 | 0.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.